APA

Stegen B., Nieto A., Albrecht V., Maas J., Orth M., Neumaier K., Reinhardt S., Weick-Kleemann M., Goetz W., Reinhart M., Parodi K., Belka C., Niyazi M. & Lauber K. (20201020). Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study. : Radiation oncology (London, England).

Chicago

Stegen Benjamin, Nieto Alexander, Albrecht Valerie, Maas Jessica, Orth Michael, Neumaier Klement, Reinhardt Sabine, Weick-Kleemann Moritz, Goetz Wilfried, Reinhart Merle, Parodi Katia, Belka Claus, Niyazi Maximilian and Lauber Kirsten. 20201020. Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study. : Radiation oncology (London, England).

Harvard

Stegen B., Nieto A., Albrecht V., Maas J., Orth M., Neumaier K., Reinhardt S., Weick-Kleemann M., Goetz W., Reinhart M., Parodi K., Belka C., Niyazi M. and Lauber K. (20201020). Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study. : Radiation oncology (London, England).

MLA

Stegen Benjamin, Nieto Alexander, Albrecht Valerie, Maas Jessica, Orth Michael, Neumaier Klement, Reinhardt Sabine, Weick-Kleemann Moritz, Goetz Wilfried, Reinhart Merle, Parodi Katia, Belka Claus, Niyazi Maximilian and Lauber Kirsten. Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study. : Radiation oncology (London, England). 20201020.